BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35077449)

  • 1. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    Bhaskaran K; Rentsch CT; Hickman G; Hulme WJ; Schultze A; Curtis HJ; Wing K; Warren-Gash C; Tomlinson L; Bates CJ; Mathur R; MacKenna B; Mahalingasivam V; Wong A; Walker AJ; Morton CE; Grint D; Mehrkar A; Eggo RM; Inglesby P; Douglas IJ; McDonald HI; Cockburn J; Williamson EJ; Evans D; Parry J; Hester F; Harper S; Evans SJ; Bacon S; Smeeth L; Goldacre B
    PLoS Med; 2022 Jan; 19(1):e1003871. PubMed ID: 35077449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Mathur R; Rentsch CT; Morton CE; Hulme WJ; Schultze A; MacKenna B; Eggo RM; Bhaskaran K; Wong AYS; Williamson EJ; Forbes H; Wing K; McDonald HI; Bates C; Bacon S; Walker AJ; Evans D; Inglesby P; Mehrkar A; Curtis HJ; DeVito NJ; Croker R; Drysdale H; Cockburn J; Parry J; Hester F; Harper S; Douglas IJ; Tomlinson L; Evans SJW; Grieve R; Harrison D; Rowan K; Khunti K; Chaturvedi N; Smeeth L; Goldacre B;
    Lancet; 2021 May; 397(10286):1711-1724. PubMed ID: 33939953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.
    Bhaskaran K; Rentsch CT; MacKenna B; Schultze A; Mehrkar A; Bates CJ; Eggo RM; Morton CE; Bacon SCJ; Inglesby P; Douglas IJ; Walker AJ; McDonald HI; Cockburn J; Williamson EJ; Evans D; Forbes HJ; Curtis HJ; Hulme WJ; Parry J; Hester F; Harper S; Evans SJW; Smeeth L; Goldacre B
    Lancet HIV; 2021 Jan; 8(1):e24-e32. PubMed ID: 33316211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.
    Williamson EJ; McDonald HI; Bhaskaran K; Walker AJ; Bacon S; Davy S; Schultze A; Tomlinson L; Bates C; Ramsay M; Curtis HJ; Forbes H; Wing K; Minassian C; Tazare J; Morton CE; Nightingale E; Mehrkar A; Evans D; Inglesby P; MacKenna B; Cockburn J; Rentsch CT; Mathur R; Wong AYS; Eggo RM; Hulme W; Croker R; Parry J; Hester F; Harper S; Douglas IJ; Evans SJW; Smeeth L; Goldacre B; Kuper H
    BMJ; 2021 Jul; 374():n1592. PubMed ID: 34261639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study.
    Simpson CR; Robertson C; Vasileiou E; Moore E; McCowan C; Agrawal U; Stagg HR; Docherty A; Mulholland R; Murray JLK; Ritchie LD; McMenamin J; Sheikh A
    Lancet Digit Health; 2021 Aug; 3(8):e517-e525. PubMed ID: 34238721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform.
    ; Tazare J; Walker AJ; Tomlinson LA; Hickman G; Rentsch CT; Williamson EJ; Bhaskaran K; Evans D; Wing K; Mathur R; Wong AY; Schultze A; Bacon S; Bates C; Morton CE; Curtis HJ; Nightingale E; McDonald HI; Mehrkar A; Inglesby P; Davy S; MacKenna B; Cockburn J; Hulme WJ; Warren-Gash C; Bhate K; Nitsch D; Powell E; Mulick A; Forbes H; Minassian C; Croker R; Parry J; Hester F; Harper S; Eggo RM; Evans SJ; Smeeth L; Douglas IJ; Goldacre B
    Wellcome Open Res; 2022; 7():142. PubMed ID: 37362009
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.
    Forbes H; Morton CE; Bacon S; McDonald HI; Minassian C; Brown JP; Rentsch CT; Mathur R; Schultze A; DeVito NJ; MacKenna B; Hulme WJ; Croker R; Walker AJ; Williamson EJ; Bates C; Mehrkar A; Curtis HJ; Evans D; Wing K; Inglesby P; Drysdale H; Wong AYS; Cockburn J; McManus R; Parry J; Hester F; Harper S; Douglas IJ; Smeeth L; Evans SJW; Bhaskaran K; Eggo RM; Goldacre B; Tomlinson LA
    BMJ; 2021 Mar; 372():n628. PubMed ID: 33737413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
    Ayoubkhani D; Khunti K; Nafilyan V; Maddox T; Humberstone B; Diamond I; Banerjee A
    BMJ; 2021 Mar; 372():n693. PubMed ID: 33789877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort.
    Sipilä PN; Heikkilä N; Lindbohm JV; Hakulinen C; Vahtera J; Elovainio M; Suominen S; Väänänen A; Koskinen A; Nyberg ST; Pentti J; Strandberg TE; Kivimäki M
    Lancet Infect Dis; 2021 Nov; 21(11):1557-1567. PubMed ID: 34166620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
    Zheng B; Green ACA; Tazare J; Curtis HJ; Fisher L; Nab L; Schultze A; Mahalingasivam V; Parker EPK; Hulme WJ; Bacon SCJ; DeVito NJ; Bates C; Evans D; Inglesby P; Drysdale H; Davy S; Cockburn J; Morton CE; Hickman G; Ward T; Smith RM; Parry J; Hester F; Harper S; Mehrkar A; Eggo RM; Walker AJ; Evans SJW; Douglas IJ; MacKenna B; Goldacre B; Tomlinson LA
    BMJ; 2022 Nov; 379():e071932. PubMed ID: 36384890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
    Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA; Aliabadi S; Seaman SR; Harris RJ; Hope R; Lopez-Bernal J; Gallagher E; Charlett A; De Angelis D; Presanis AM; Dabrera G;
    Lancet Infect Dis; 2022 Jan; 22(1):35-42. PubMed ID: 34461056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data.
    Cummins L; Ebyarimpa I; Cheetham N; Tzortziou Brown V; Brennan K; Panovska-Griffiths J
    Influenza Other Respir Viruses; 2021 Sep; 15(5):577-588. PubMed ID: 33942510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study.
    Wilcox CR; Islam N; Dambha-Miller H
    BMJ Open Respir Res; 2021 Mar; 8(1):. PubMed ID: 33664123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020.
    Dennis JM; Mateen BA; Sonabend R; Thomas NJ; Patel KA; Hattersley AT; Denaxas S; McGovern AP; Vollmer SJ
    Diabetes Care; 2021 Jan; 44(1):50-57. PubMed ID: 33097559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated antibiotic exposure and risk of hospitalisation and death following COVID-19 infection (OpenSAFELY): a matched case-control study.
    Yang YT; Wong D; Ashcroft DM; Massey J; MacKenna B; Fisher L; Mehrkar A; Bacon SC; ; Hand K; Zhong X; Fahmi A; Goldacre B; van Staa T; Palin V
    EClinicalMedicine; 2023 Jul; 61():102064. PubMed ID: 37528841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk groups for severe COVID-19 in a whole of population cohort in Australia.
    Liu B; Spokes P; He W; Kaldor J
    BMC Infect Dis; 2021 Jul; 21(1):685. PubMed ID: 34266396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study.
    Bloom CI; Cullinan P; Wedzicha JA
    Am J Respir Crit Care Med; 2022 Jan; 205(1):36-45. PubMed ID: 34669568
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
    Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
    Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
    Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
    Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.